Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2004 Oct 18;2004(4):CD004222.
doi: 10.1002/14651858.CD004222.pub2.

Treatment for women with postpartum iron deficiency anaemia

J Dodd  1 , M R Dare, P Middleton
Affiliations
Meta-Analysis

Treatment for women with postpartum iron deficiency anaemia

J Dodd et al. Cochrane Database Syst Rev. .

Abstract

Background: Postpartum anaemia is associated with breathlessness, tiredness, palpitations and maternal infections. Blood transfusions or iron supplementation have been used in the treatment of iron deficiency anaemia. Recently other anaemia treatments, in particular erythropoietin therapy, have also been used.

Objectives: To assess the clinical effects of treatments for postpartum anaemia, including oral, intravenous or subcutaneous iron/folate supplementation and erythropoietin administration, and blood transfusion.

Search strategy: We searched the Cochrane Pregnancy and Childbirth Group trials register (30 May 2004), the Cochrane Central Register of Controlled Trials (The Cochrane Library, Issue 1, 2003), MEDLINE (1966 to March 2003), EMBASE (1980 to March 2003), Current Contents and ACP Journal Club (from inception to March 2003).

Selection criteria: Randomised controlled trials (RCTs) comparing therapy for postpartum iron deficiency anaemia (oral, intravenous or subcutaneous administration of iron, folate, erythropoietin or blood transfusion) with placebo, another treatment or no treatment.

Data collection and analysis: Two reviewers independently assessed trial quality and extracted data.

Main results: Six included RCTs involving 411 women described treatment with erythropoietin or iron as their primary interventions. No RCTs were identified that assessed treatment with blood transfusion. Few outcomes relating to clinical maternal and neonatal factors were reported: studies focused largely on surrogate outcomes such as haematological indices. Overall, the methodological quality of the included RCTs was reasonable; however, their usefulness in this review is restricted by the interventions and outcomes reported. When compared with iron therapy only, erythropoietin increased the likelihood of lactation at discharge from hospital (1 RCT, n = 40; relative risk (RR) 1.90, 95% confidence interval (CI) 1.21 to 2.98). No apparent effect on need for blood transfusions was found, when erythropoietin plus iron was compared to treatment with iron only (2 RCTs, n = 100; RR 0.20, 95% CI 0.01 to 3.92), although the RCTs may have been of insufficient size to rule out important clinical differences. Haematological indices (haemoglobin and haemocrit) showed some increases when erythropoietin was compared to iron only, iron and folate, but not when compared with placebo.

Reviewers' conclusions: There is some limited evidence of favourable outcomes for treatment of postpartum anaemia with erythropoietin. However, most of the available literature focuses on laboratory haematological indices, rather than clinical outcomes. Further high-quality trials assessing the treatment of postpartum anaemia with iron supplementation and blood transfusions are required. Future trials may also examine the significance of the severity of anaemia in relation to treatment, and an iron-rich diet as an intervention.

PubMed Disclaimer

Conflict of interest statement

None known.

Figures

1.3
1.3. Analysis
Comparison 1 EPO i.v. versus placebo i.v., Outcome 3 Haemoglobin (g/dL) within 2 weeks after treatment.
1.4
1.4. Analysis
Comparison 1 EPO i.v. versus placebo i.v., Outcome 4 Haematocrit (%) within 2 weeks after treatment.
2.1
2.1. Analysis
Comparison 2 EPO + iron versus iron, Outcome 1 Use of blood transfusions.
2.2
2.2. Analysis
Comparison 2 EPO + iron versus iron, Outcome 2 Lactating.
2.3
2.3. Analysis
Comparison 2 EPO + iron versus iron, Outcome 3 Thromboembolic complications.
2.4
2.4. Analysis
Comparison 2 EPO + iron versus iron, Outcome 4 Anaphylactic/serious reaction.
2.6
2.6. Analysis
Comparison 2 EPO + iron versus iron, Outcome 6 Haemoglobin (g/dL) within 2 weeks after treatment.
2.7
2.7. Analysis
Comparison 2 EPO + iron versus iron, Outcome 7 Haemoglobin increase (%) within 2 weeks after treatment.
2.8
2.8. Analysis
Comparison 2 EPO + iron versus iron, Outcome 8 Haemoglobin (g/dL) > 2 weeks to 6 weeks after treatment.
2.10
2.10. Analysis
Comparison 2 EPO + iron versus iron, Outcome 10 Haematocrit (%) within 2 weeks after treatment.
2.11
2.11. Analysis
Comparison 2 EPO + iron versus iron, Outcome 11 Haematocrit > 35% 2 weeks after treatment.
2.12
2.12. Analysis
Comparison 2 EPO + iron versus iron, Outcome 12 Haematocrit (%) > 2 weeks to 6 weeks after treatment.
3.1
3.1. Analysis
Comparison 3 EPO s.c. versus EPO i.v., Outcome 1 Adverse effects reported for EPO.
3.2
3.2. Analysis
Comparison 3 EPO s.c. versus EPO i.v., Outcome 2 Haemoglobin (g/dL) within 2 weeks after treatment.
3.3
3.3. Analysis
Comparison 3 EPO s.c. versus EPO i.v., Outcome 3 Haemoglobin (g/dL) > 2 weeks to 6 weeks after treatment.
3.4
3.4. Analysis
Comparison 3 EPO s.c. versus EPO i.v., Outcome 4 Haematocrit (%) within 2 weeks after treatment.
3.5
3.5. Analysis
Comparison 3 EPO s.c. versus EPO i.v., Outcome 5 Haematocrit (%) > 2 weeks to 6 weeks after treatment.
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Breymann 1996 {published data only}
    1. Breymann C, Zimmermann R, Huch R, Huch A. Use of recombinant human erythropoietin in combination with parenteral iron in the treatment of postpartum anaemia. European Journal of Clinical Investigation 1996;26:123‐30. - PubMed
    1. Krafft A, Breymann C, Huttner C, Huch R, Huch A. Erythropoietic quality of maternal milk. Lancet 1999;354(9180):778. - PubMed
Breymann 2000 {published data only}
    1. Breymann C, Richter C, Huttner C, Huch A. Effectiveness of recombinant erythropoietin and iron sucrose vs. iron therapy only, in patients with postpartum anaemia and blunted erythropoiesis. European Journal of Clinical Investigation 2000;30:154‐61. - PubMed
Lebrecht 1995 {published data only}
    1. Lebrecht A, Haberlin F, Eberhard J. Anemia in puerperium: parenteral iron substitution renders erythropoietin therapy dispensable [Anamie im Wochenbett: parenterale Eisensubstitution macht Erythropoetin‐Therapie entbehrlich]. Geburtshilfe und Frauenheilkunde 1995;55(3):167‐70. - PubMed
Makrydimas 1998 {published data only}
    1. Makrydimas G, Lolis D, Lialios G, Tsiara S, Georgiou I, Bourantas K. Recombinant human erythropoietin treatment of postpartum anaemia, preliminary results. European Journal of Obstetrics & Gynecology and Reproductive Biology 1998;81:27‐31. - PubMed
Meyer 1995 {published data only}
    1. Meyer J, Eichhorn K, Vetter K, Christen S, Schleusner E, Klos A, et al. Does recombinant human erythropoietin not only treat anemia but reduce postpartum (emotional) distress as well?. Journal of Perinatal Medicine 1995;23:99‐109. - PubMed
Zimmermann 1994 {published data only}
    1. Zimmermann R, Breymann C, Huch R, Huch A. rHuEPO in the treatment of postpartum anemia: subcutaneous versus intravenous administration. Clinical Investigation 1994;72(6 Suppl):S25‐30. - PubMed

References to studies excluded from this review

Casparis 1996 {published data only}
    1. Casparis D, Carlo P, Branconi F, Grossi A, Merante D, Gafforio L. Effectiveness and tolerance of oral doses of liquid ferrous gluconate in iron deficiency anaemia during pregnancy and in the immediate post‐natal period: comparisons with other liquid or solid formulations containing bivalent or trivalent iron. Minerva Ginecologica 1996;48:511‐8. - PubMed
Danko 1990 {published data only}
    1. Danko J, Huch R, Huch A. Epoetin alfa for treatment of postpartum anaemia. Lancet 1990;335:737‐8. - PubMed
Huch 1992 {published data only}
    1. Huch A, Eichhorn K, Danko J, Lauener P, Huch R. Recombinant human erythropoietin in the treatment of postpartum anemia. Obstetrics & Gynecology 1992;80:127‐31. - PubMed
Mara 2001 {published data only}
    1. Mara M, Zivny J, Eretova V, Kvasnicka J, Kuzel D, Umlaufova A, et al. Changes in markers of anemia and iron metabolism and how they are influenced by antianemics in postpartum period. Acta Obstetrica Gynecologica Scandinavica 2001;80:142‐8. - PubMed
Osmond 1953 {published data only}
    1. Osmond TG. Post‐partum anaemia, a practical treatment. Practitioner 1953;171:77‐80. - PubMed
Picha 1975 {published data only}
    1. Picha E. A new direction for iron therapy [Ein neuer Weg der Eisentherapie]. Geburtshilfe und Frauenheilkunde 1975;35(10):792‐5. - PubMed
Zimmermann 1995 {published data only}
    1. Zimmermann R, Breymann C, Richter C, Huch R, Huch A. rhEPO treatment of postpartum anaemia. Journal of Perinatal Medicine 1995;23:111‐7. - PubMed

References to studies awaiting assessment

Backe 2009 {published data only}
    1. Backe B. A 6‐week randomised, open comparative, multi‐centre study of intravenous ferric carboxymaltose (ferinject) and oral iron (duroferon) for treatment of post partum anemia. http://clinicaltrials.gov/ct2/show/record/NCT00929409 (accessed 5 June 2012) 2009.
Beard 2005 {published data only}
    1. Beard JL, Hendricks MK, Perez EM, Murray‐Kolb LE, Berg A, Vernon‐Feagans L, et al. Maternal iron deficiency anemia affects postpartum emotions and cognition. Journal of Nutrition 2005;135(2):267‐72. - PubMed
Bhandal 2004 {published data only}
    1. Bhandal N, Russell R. Intravenous versus oral iron therapy for postpartum anaemia. International Journal of Obstetric Anesthesia 2004;13(3):S7. - PubMed
Bhandal 2006 {published data only}
    1. Bhandal N, Russell R. Intravenous versus oral iron therapy for postpartum anaemia. BJOG: an International Journal of Obstetrics and Gynaecology 2006;113(11):1248‐52. - PubMed
Breymann 2007 {published data only}
    1. Breymann C, Seefried B, Stahel M, Geisser P, Canclini C. Milk iron content in breast‐feeding mothers after administration of intravenous iron sucrose complex. Journal of Perinatal Medicine 2007;35(2):115‐8. - PubMed
Breymann 2008 {published data only}
    1. Breymann C, Gliga F, Bejenariu C, Strizhova N. Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia. International Journal of Gynecology & Obstetrics 2008;101(1):67‐73. - PubMed
Daniilidis 2011 {published data only}
    1. Daniilidis A, Giannoulis C, Pantelis A, Tantanasis T, Dinas K. Total infusion of low molecular weight iron‐dextran for treating postpartum anemia. Clinical and Experimental Obstetrics and Gynecology 2011;38(2):159‐61. - PubMed
Dede 2005 {published data only}
    1. Dede A, Uygur D, Yilmaz B, Mungan T, Ugur M. Intravenous iron sucrose complex vs. oral ferrous sulfate for postpartum iron deficiency anemia. International Journal of Gynecology & Obstetrics 2005;90(3):238‐9. - PubMed
Haidar 2005 {published data only}
    1. Haidar J, Umeta M, Kogi‐Makau W. Effect of iron supplementation on serum zinc status of lactating women in Addis Ababa, Ethiopia. East African Medical Journal 2005;82(7):349‐52. - PubMed
Hashmi 2006 {published data only}
    1. Hashmi Z, Bashir G, Azeem P, Shah S. Effectiveness of intra‐venous iron sucrose complex versus intra‐muscular iron sorbitol in iron deficiency anemia. Annals of Pakistan Institute of Medical Sciences 2006;2(3):188‐91.
Huch 1990 {published data only}
    1. Huch A, Huch R. EPO (rHuEPO) use in obstetrics. Proceedings of Ross Laboratories Special Conference, Hot Topics '90 in Neonatology; 1990 Dec 9‐11; Washington DC, USA. 1990:79‐80.
Jansen 2007 {published data only}
    1. Jansen AJG, Duvekot JJ, Essink‐Bot ML, Hop WCJ, Rhenen DJ. Multicentre clinical study into the optimal blood transfusion policy in patients with postpartum haemorrhage: The 'Wellbeing of obstetric patients on minimal blood transfusions' (WOMB) study [Een klinisch multicentrisch onderzoek naar het optimale bloedtransfusiebeleid bij patienten met een fluxus post partum: De 'Wellbeing of obstetric patients on minimal blood transfusions'(WOMB)‐studie]. Nederlands Tijdschrift voor Geneeskunde 2007;151(39):2170‐2. - PubMed
Krafft 2011 {published data only}
    1. Krafft A, Breymann C. Iron sucrose with and without recombinant erythropoietin for the treatment of severe postpartum anemia: a prospective, randomized, open‐label study. Journal of Obstetrics and Gynaecology Research 2011;37(2):119‐24. - PubMed
Krauss 1972 {published data only}
    1. Krauss V, Nowotny D, Scharifzadeh AH. Effect and tolerance of oral iron therapy in the puerperium. Munchener Medizinische Wochenschrift 1972;114(43):1877‐9. - PubMed
Mara 1999 {published data only}
    1. Mara M, Eretova V, Zivny J, Kvasnicka J, Umlaufova A, Marova E. Anemia and its treatment with peroral anti‐anemia agents in women during the postpartum period. [Czech]. Ceska Gynekologie 1999;64:153‐8. - PubMed
Murray‐Kolb 2009 {published data only}
    1. Murray‐Kolb LE, Beard JL. Iron deficiency and child and maternal health. American Journal of Clinical Nutrition 2009;89(3):946S‐50S. - PubMed
Palacio 2007 {published data only}
    1. Palacio M. Intravenous iron versus oral iron for severe postpartum anemia randomized trial. http://clinicaltrials.gov/ct2/show/record/NCT00660933 (accessed 5 June 2012) 2007.
Perez 2005 {published data only}
    1. Perez EM, Hendricks MK, Beard JL, Murray‐Kolb LE, Berg A, Tomlinson M, et al. Mother‐infant interactions and infant development are altered by maternal iron deficiency anemia. Journal of Nutrition 2005;135(4):850‐5. - PubMed
Prick 2010 {published data only}
    1. Prick BW, Steegers EAP, Jansen AG, Hop WCJ, Essink‐Bot M‐L, Peters NCJ, et al. Well being of obstetric patients on minimal blood transfusions (WOMB trial). BMC Pregnancy and Childbirth 2010;10:83. - PMC - PubMed
Prick 2012 {published data only}
    1. Prick BW, Jansen AJG, Steegers EAP, Hop WCJ, Essink‐Bot ML, Uyl‐de Groot CA, et al. RBC transfusion leads to an improvement of physical fatigue in women with acute postpartum anemia: the WOMB study (NCT00335023). American Journal of Obstetrics and Gynecology 2012;206(Suppl 1):S41‐2.
Seid 2007 {published data only}
    1. Seid MH, Rogers R, Dinh Q. Treating postpartum anemia with intravenous ferric carboxymaltose in a randomized controlled study. American Journal of Obstetrics and Gynecology 2007;197(6 Suppl 1):S26, Abstract no: 55.
Seid 2008 {published data only}
    1. Seid MH, Derman RJ, Baker JB, Banach W, Goldberg C, Rogers R. Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial. American Journal of Obstetrics and Gynecology 2008;199(4):435.e‐1‐435.e7. - PubMed
Tam 2005 {published data only}
    1. Tam KF, Lee CP, Pun TC. Mild postnatal anemia: is it a problem?. American Journal of Perinatology 2005;22(7):345‐9. - PubMed
Van der Woude 2011 {published data only}
    1. Woude D. Iron and folic acid v.s. iron solely in the treatment of post partum anaemia; effects on haemoglobin and health status. Netherlands Trial Register (http://www.trialregister.nl) (accessed 8 July 2011) 2011.
Van Rhenen 2005 {published data only}
    1. Rhenen DJ. Wellbeing of obstetric patients on minimal bloodtranfusions study ‐ WOMB study. Netherlands Trial Register (http://www.trialregister.nl) (accessed 1 November 2005)) 2005.
Van Wyck 2007 {published data only}
    1. Wyck DB, Martens MG, Seid MH, Baker JB, Mangione A. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial. Obstetrics & Gynecology 2007;110(2 Pt 1):267‐78. - PubMed
Verma 2011 {published data only}
    1. Verma S, Inamdar SA, Malhotra N. Intravenous iron therapy versus oral iron in postpartum patients in rural area. Journal of SAFOG 2011;3(2):67‐70.
Wagstrom 2007 {published data only}
    1. Wagstrom E, Akesson A, Rooijen M, Larson B, Bremme K. Erythropoietin and intravenous iron therapy in postpartum anaemia. Acta Obstetricia et Gynecologica Scandinavica 2007;86(8):957‐62. - PubMed
Westad 2008 {published data only}
    1. Westad S, Backe B, Salvesen KA, Nakling J, Okland I, Borthen I, et al. A 12‐week randomised study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anemia. Acta Obstetricia et Gynecologica Scandinavica 2008;87(9):916‐23. - PubMed
Westad 2009 {published data only}
    1. Westad S, Backe B, Salvesen K, Nakling J, Okland I, Borthen I, et al. A 12‐week randomised, multi‐centre study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anaemia. International Journal of Gynecology & Obstetrics 2009;107(Suppl 2):S377.

Additional references

AADRB 2002
    1. Epoetin alfa and pure red cell aplasia. Australian Adverse Drug Reactions Bulletin; www.health.gov.au/tga/adr/aadrd/aadr0208.htm [accessed 16 December 2003] August 2002.
Atkinson 1994
    1. Atkinson L, Baxley E. Post partum fatigue. American Family Physician 1994;50(1):113‐8. - PubMed
Casadevall 2002
    1. Casadevall N, Nataf J, Viron B, Kolta A, Kiladjian J‐J, Martin‐Dupont P, et al. Pure red‐cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. New England Journal of Medicine 2002;346(7):469‐75. - PubMed
Clarke 2003
    1. Clarke M, Oxman A, editors. Cochrane Reviewers' Handbook 4.2.0 [updated March 2003]. Review Manager (RevMan) [computer program]. Oxford, UK: The Cochrane Collaboration, 2003.
Davis 1990
    1. Davis HP. Erythropoietin for patient refusing blood transfusion. Lancet 1990;336:384‐5. - PubMed
Dudrick 1986
    1. Dudrick S, O'Donnell J, Matheny R, Unkel S, Raleigh D. Stimulation of hematopoiesis as an alternative to transfusion. Southern Medical Journal 1986;79(6):669‐73. - PubMed
Ekanem 1996
    1. Ekanem A, Etuk S, Samson‐Akpan U. The influence of cultural practice on puerperal anemia. International Journal of Gynecology & Obstetrics 1996;55:169‐70. - PubMed
Gibbs 1980
    1. Gibbs R. Clinical risk factors for puerperal infection. Obstetrics & Gynecology 1980;55(5 Suppl):178S‐84S. - PubMed
Gilbert 1987
    1. Gilbert L, Porter W, Brown VA. Postpartum haemorrhage ‐ a continuing problem. British Journal of Obstetrics and Gynaecology 1987;94:67‐71. - PubMed
Harrison 1989
    1. Harrison K. Maternal mortality in developing countries. British Journal of Obstetrics and Gynaecology 1989;96:1‐3. - PubMed
Klapholz 1990
    1. Klapholz H. Blood transfusion in contemporary obstetric practice. Obstetrics & Gynecology 1990;75(6):940‐3. - PubMed
Kumar 1989
    1. Kumar R, Sharma A, Barik S, Kumar V. Maternal mortality inquiry in a rural community of North India. International Journal of Gynecology & Obstetrics 1989;29:313‐9. - PubMed
Mahomed 2003
    1. Mahomed K. Iron supplementation in pregnancy (Cochrane Review). The Cochrane Library 2003, Issue 4.
Markova 2015
    1. Markova V, Norgaard A, Jørgensen KJ, Langhoff‐Roos J. Treatment for women with postpartum iron deficiency anaemia. Cochrane Database of Systematic Reviews 2015, Issue 8. [DOI: 10.1002/14651858.CD010861.pub2] - DOI - PMC - PubMed
Naef 1995a
    1. Naef R, Washburne J, Martin R, Magann E, Scanlon P, Morrison J. Hemorrhage associated with cesarean delivery: when is transfusion needed. Journal of Perinatology 1995;15(1):32‐5. - PubMed
Naef 1995b
    1. Naef R, Morrison J. Transfusion therapy in pregnancy. Clinical Obstetrics and Gynecology 1995;38(3):547‐57. - PubMed
Nolan 1991
    1. Nolan T, Gallup D. Massive transfusion: a current review. Obstetrical and Gynecological Survey 1991;46(5):289‐95. - PubMed
RevMan 2004 [Computer program]
    1. The Cochrane Collaboration. Review Manager (RevMan). Version 4.2.3. Oxford, UK: The Cochrane Collaboration, 2004.
Rosenfield 1989
    1. Rosenfield A. Maternal mortality in developing countries ‐ an ongoing but neglected 'epidemic'. JAMA 1989;262(3):376‐9. - PubMed
Skolnick 1992
    1. Skolnick A. Transfusion medicine faces time of major 'challenges and changes'. JAMA 1992;268(6):697‐700. - PubMed
Vora 1998
    1. Vora M, Gruslin A. Erythropoietin in obstetrics. Obstetrical and Gynecological Survey 1998; Vol. 53, issue 8:500‐8. - PubMed
Waymack 1990
    1. Waymack J, Yurt R. The effect of blood transfusions on immune function. Journal of Surgical Research 1990;48:147‐53. - PubMed
WHO 1999
    1. World Health Organization. Reduction of maternal mortality. A joint WHO/UNFPA/UNICEF/World Bank statement. Geneva: WHO, 1999.
WHO 2001
    1. World Health Organization, United Nations Children's Fund, United Nations University. Iron deficiency anaemia; Assessment, Prevention and Control; A guide for programme managers. Geneva: World Health Organization, 2001.

MeSH terms